Quadria Capital is an institutional investor (Growth Equity) founded in 2009 and headquartered in Singapore. Quadria Capital is Asia's leading healthcare private equity firm. The firm takes an industrial approach to partnership, leveraging deep domain expertise, operational experience, and industry network. Healthcare ecosystem investments span Diagnostics, Out-of-Hospitals, Hospitals, Medical Device/Personal Care, Clinical Trials, Pharmaceuticals, Artificial Intelligence, and Deep Distribution across 8 markets in Asia. Private equity fund focused on healthcare sector. Fund Philosophy: We invest in large growth, scalable healthcare companies in Asia with clear market differentiation, strong management teams, and potential to emerge as market leaders. Notable portfolio companies: NephroPlus (Asia's largest dialysis network), Maxivision (eye care chain), Straits Orthopaedics (orthopedic implants manufacturer).

Stage

Private Equity, Private Equity

HQ

Singapore, Singapore

Founded

2009

Website

https://quadriacapital.com

LinkedIn

https://linkedin.com/company/quadria-capital-investment-management

Twitter

http://twitter.com/quadriacapital

Preparing to pitch Quadria Capital?

CrackTheDeck analyzes your pitch deck before the meeting — structure, narrative, investor fit.